Articles
GeoVax Receives Notice of Allowance for Zika Vaccine Patent
ATLANTA, GA, Jan. 25, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that the U.S. Patent and Trademark Office issued a Notice of Allowance for Patent Application No. 17/000,768 titled, “Method for Generating a ZIKV Immune Response Utilizing a Recombinant Modified…
Read MoreNew Report Shows Life Sciences as a Major Economic and Innovation Engine for Georgia
ATLANTA–(BUSINESS WIRE)–According to a new industry report released by the Center for Global Health Innovation (The Center) and TEConomy Partners, a global leader in research and analysis, Georgia’s life sciences industry has experienced strong and steady employment growth in recent years, outpacing even the rapidly growing national industry in its private sector industrial components and…
Read MoreGeorgia Tech is expanding Science Square. The first building just sold.
As economic headwinds continue to complicate office deals in Atlanta, the only completed building part of Georgia Tech’s Science Square has traded hands. Ancora Partners, which is headquartered in Durham, North Carolina, paid $85 million to acquire the five-story, 128,000-square-foot building, according to Fulton County property deeds. This value is more than 25% higher than…
Read MoreFive life sciences trends to watch for in 2023
Here’s the good news first – when it comes to deal flow and M&A activity, life sciences companies have been on a tear in the past couple of years. Just this year alone, among the largest biotech deals, Pfizer Inc. (NYSE: PFE) bought Biohaven Pharma for $12 billion, Bristol-Myers Squibb (NYSE: BMY) bought Turning Point for $4 billion and…
Read MoreU.S. biotech is a major economic driver with a broad range, report says
The U.S. biotech sector is a vital economic engine in all 50 states, providing 2.1 million jobs and a $2.9 trillion impact on the economy in 2021, according to a comprehensive report published today. The report, produced by the Biotechnology Innovation Organization (BIO) and the Council of State Bioscience Associations (CSBA) in partnership with TEConomy, gives extensive data…
Read MoreDeerfield firm’s grant from Bill Gates-led fund will make green jet fuel as cheap as fossil fuels
LanzaJet, the startup backed by Breakthrough Energy, is building its first commercial plant in Georgia and expects to begin production next year. (Bloomberg)—The burgeoning market for sustainable jet fuel will soon reach a milestone, with a plant capable of turning out for the first time a lower-emission fuel at the same price as fossil fuel-based…
Read MoreGov. Kemp Announces Appointments to Rare Disease Advisory Council
Atlanta, GA – Governor Brian P. Kemp today announced his appointments to the Georgia Rare Disease Advisory Council, created by House Bill 918. The Council is comprised of 16 qualified professionals, persons living with rare diseases, and caregivers appointed by the Governor, Lieutenant Governor, and Speaker of the House. It will advise the General Assembly and other…
Read MoreFACT SHEET: President Biden Takes Action to Lower Health Care and Prescription Drug Costs for Americans
To mark the start of Medicare Open Enrollment season, President Biden will travel to Irvine, California, on October 14th and Portland, Oregon, on October 15th to highlight how seniors can take advantage of the Inflation Reduction Act’s cost-saving provisions as they shop for new health insurance plans. The President will also sign an Executive Order directing the…
Read MoreThe Center for Global Health Innovation Announces Plenary and Featured Speakers for Annual Bio Innovation Summit
Life Sciences Industry to Welcome Dr. Julie Gerberding, CEO of the Foundation for the National Institutes of Health & Dr. Vasant (Vas) Narasimhan, Novartis CEO The Center for Global Health Innovation (CGHI/The Center) today announced keynote and featured speakers for its annual Bio Innovation Summit scheduled for Tuesday, October 11, 2022, at Mercedes Benz Stadium.…
Read MoreThe Licensing of Academic Patents Contributed Up to $1.9 Trillion to the US Economy, Supported up to 6.5 Million Jobs in the last 25 Years New Report Highlights the Importance of Research and Public-Private Partnerships
The licensing of university and nonprofit research has made a significant contribution to US gross domestic product (GDP), industrial gross output, and jobs over the last 25 years and underscores the importance of basic and applied research to the US economy, as well as the demand for public-private partnerships. The findings are based on an…
Read More